This project aims to evaluate the feasibility and effectiveness of using in vitro and in vivo models to characterize FcRn binding and to estimate the elimination PK parameters of antibody drug candidates in human. This will include: data analysis, comparison of in-vitro and in-vivo data, data mining, in silico models, reporting.
Major accountabilities:
Minimu Requirements:
Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each other. Combining to achieve breakthroughs that change patients’ lives. Ready to create a brighter future together? https://www.novartis.com/about/strategy/people-and-culture
Join our Novartis Network: Not the right Novartis role for you? Sign up to our talent community to stay connected and learn about suitable career opportunities as soon as they come up: https://talentnetwork.novartis.com/network
Benefits and Rewards: Read our handbook to learn about all the ways we’ll help you thrive personally and professionally: https://www.novartis.com/careers/benefits-rewards